A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(9 sites)

Georgia

Batumi Dialysis and Nephrology Center, Batumi

Clinical Center for Nephrology Development, Tbilisi

L.Managadze National Center of Urology, Tbilisi

Tbilisi Heart And Vascular Clinic, Tbilisi

South Korea

Korea University Ansan Hospital, Ansan

St Mary's Incheon Hospital, Incheon

Kangdong KyungHee University Hospital, Seoul

St Mary's Seoul Hospital, Seoul

St Mary's Yeouido Hospital, Seoul